These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 19435196)
1. [Risk of locally-advanced recurrences of breast cancer following organ-saving surgery]. Gurbanov SS; Matsko DE; Kanaev SV; Semiglazov VF Vopr Onkol; 2009; 55(1):33-7. PubMed ID: 19435196 [TBL] [Abstract][Full Text] [Related]
2. Frequency of locoregional and axillary recurrences among patients following breast cancer operations. Bakos I; Almássy S Acta Chir Hung; 1997; 36(1-4):9-10. PubMed ID: 9408268 [TBL] [Abstract][Full Text] [Related]
3. [Perspectives in use of surgery for disintegrating breast tumor]. Topuzov EE; Sadigova SN; Lemekhov VG; Aristov RL; Danilov AG; Bozhok AA; Kasianova MN; Klimov NA; Topuzov RE Vopr Onkol; 2011; 57(4):502-4. PubMed ID: 22191242 [TBL] [Abstract][Full Text] [Related]
4. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803 [TBL] [Abstract][Full Text] [Related]
5. [Incidence of local recurrence after breast preserving surgery]. Garami Z; Szluha K; Kósa C; Fülöp B; Lukács G Magy Seb; 2006 Jun; 59(3):179-83. PubMed ID: 16937793 [TBL] [Abstract][Full Text] [Related]
6. [Sparing and organ-saving operations in breast cancer]. Semiglazov VF; Chagunava OL Vopr Onkol; 1990; 36(5):535-9. PubMed ID: 2378074 [TBL] [Abstract][Full Text] [Related]
7. [Indications for adjuvant radiotherapy in primary breast-saving and ablative treatment of breast cancer]. Bahnsen J Gynakologe; 1994 Apr; 27(2):64-9. PubMed ID: 8039744 [No Abstract] [Full Text] [Related]
8. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up. Jobsen JJ; van der Palen J; Ong F Int J Radiat Oncol Biol Phys; 2008 May; 71(1):115-22. PubMed ID: 18234450 [TBL] [Abstract][Full Text] [Related]
9. Presence of extensive intraductal component in patients undergoing breast conservative surgery predicts presence of residual disease in subsequent completion mastectomy. Yiu CC; Loo WT; Lam CK; Chow LW Chin Med J (Engl); 2009 Apr; 122(8):900-5. PubMed ID: 19493411 [TBL] [Abstract][Full Text] [Related]
10. [Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast cancer (pT1-2N0M0)]. Roman LD; Fedorov KA; Krasnozhon DA Vopr Onkol; 2004; 50(1):99-100. PubMed ID: 15088531 [TBL] [Abstract][Full Text] [Related]
11. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer. Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389 [TBL] [Abstract][Full Text] [Related]
12. [Histological margin and residual disease assessment for breast carcinoma]. Sigal-Zafrani B; Fourquet A; Vincent-Salomon A; Fréneaux P; Génin P; Rosty C; Sastre-Garau X Cancer Radiother; 2003 Nov; 7 Suppl 1():120s-123s. PubMed ID: 15124553 [TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of determination of the presence and histologic grade of the intraductal component in invasive ductal carcinoma of the breast after conservative treatment]. Sarcević B; Separović R; Separović V; Oresić V; Nola N; Vrdoljak M; Marić M; Stajcer-Stitić V; Milas I; Kruslin B Lijec Vjesn; 1998; 120(1-2):4-7. PubMed ID: 9650477 [TBL] [Abstract][Full Text] [Related]
14. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy. Oouchi A; Sakata K; Masuoka H; Tamakawa M; Nagakura H; Someya M; Nakata K; Asaishi K; Okazaki M; Okazaki Y; Ohmura T; Hareyama M; Hori M; Shimokawara I; Okazaki A; Watanabe Y; Yamada T; Yuyama T; Satoh T; Hirata K Breast Cancer; 2009; 16(1):49-57. PubMed ID: 18841332 [TBL] [Abstract][Full Text] [Related]
15. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400 [TBL] [Abstract][Full Text] [Related]
16. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer. Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964 [TBL] [Abstract][Full Text] [Related]
17. Increased risk of local recurrence after breast-conserving therapy in young patients. Baltoyiannis G; Roukos DH; Fatouros M Radiother Oncol; 2008 Feb; 86(2):286-7; author reply 287-8. PubMed ID: 17963905 [No Abstract] [Full Text] [Related]